Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pancreatic beta-cell identity and function genes represent a coordinated network of transcription factors and functional proteins essential for maintaining the mature state and glucose-responsive insulin secretion of beta cells [Source: PubMed PMC5565123]. Key components include transcription factors like Pancreatic and duodenal homeobox 1 (PDX1), MAF BZIP Transcription Factor A (MAFA), and NK6 Homeobox 1 (NKX6.1), which drive the expression of the insulin gene (INS) and glucose sensors like SLC2A2 [Source: Genes & Development, 31(14), 1411-1422]. In Type 2 Diabetes, these genes are often downregulated, leading to beta-cell dedifferentiation where cells lose their specialized function and revert to a less mature state [Source: Cell, 150(6), 1223-1234]. This loss of identity is a major driver of disease progression and insulin insufficiency. Therapeutic interventions, such as GLP-1 receptor agonists, aim to preserve or restore the expression of these identity genes to maintain functional beta-cell mass [Source: Nature Reviews Endocrinology, 13(11), 635-651]. Although this is a collective gene set rather than a single molecular target, it serves as a critical framework for developing regenerative therapies and understanding islet pathophysiology.
Activation of signaling pathways that stabilize the expression of beta-cell-specific transcription factors and functional proteins to prevent dedifferentiation and maintain insulin secretion.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pancreatic beta-cell identity and function genes.